DRUG · Mapped RxNorm record
ramipril
Normalized identity: ramiprilView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan
NCT00517322
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
irbesartan
Normalized identity: irbesartanView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedLeft Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Left Atrial Volumeunresolved
Antihypertensive Drugsunresolved
Diastolic Functionunresolved
Renin Angiotensin Systemunresolved
Interventions
ramiprilDRUG · verified · RxNorm: ramipril
irbesartanDRUG · verified · RxNorm: irbesartan
Sponsors & collaborators
Università degli Studi dell'Insubrialead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00517322 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.